Overview

Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled Asthma

Status:
Completed
Trial end date:
2020-03-13
Target enrollment:
0
Participant gender:
All
Summary
Study is looking at the development of tolerance to methacholine following regular use of ipratropium bromide in mild asthmatics.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Saskatchewan
Treatments:
Bromides
Ipratropium
Methacholine Chloride
Criteria
Inclusion Criteria:

- airway responsiveness to methacholine

- adequate baseline lung function

- no respiratory infection or exposure to stimuli that may alter response to
methacholine within 4 weeks

Exclusion Criteria:

- pregnancy

- current smoker

- requirement for medications other than salbutamol that will interfere with airway
response to methacholine